Onco-Innovations Limited (NEO:ONCO)

Onco-Innovations Ratios and Metrics

Market cap in millions CAD. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Mar 9, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023
Market Capitalization	36	76	-	-
Enterprise Value	35	76	-	-
Last Close Price	0.63	1.50	-	-
PS Ratio	234.53	1164.95	-	-
PB Ratio	20.05	42.13	-	-
P/TBV Ratio	20.05	42.13	-	-
EV/Sales Ratio	227.49	1158.58	-	-
Net Debt / Equity Ratio	-0.60	-0.62	-1.40	-1.00
Asset Turnover	-	0.05	-	-
Quick Ratio	2.32	2.94	3.47	-
Current Ratio	4.40	5.41	3.47	-
Return on Equity (ROE)	-	-799.79%	-233.40%	-
Return on Assets (ROA)	-	-144.12%	-105.54%	-
Return on Capital Employed (ROCE)	-371.80%	-170.10%	-123.50%	-1.30%
Earnings Yield	-39.31%	-11.17%	-	-
Buyback Yield / Dilution	-	-905.82%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.